拱东医疗: 拱东医疗：5%以上股东、董事兼总经理提前终止减持计划暨减持股份结果公告

Summary of Key Points Core Viewpoint - The announcement details the results of a share reduction plan by Zhejiang Gongdong Medical Instrument Co., Ltd, highlighting the amounts and percentages of shares sold by key stakeholders, including the early termination of the reduction plan [1][3]. Group 1: Shareholder Reduction Details - Taizhou Jinch Investment Management Partnership (Limited Partnership) planned to reduce its holdings by up to 1,575,784 shares, representing no more than 1% of the total share capital [1]. - The total shares reduced by Taizhou Jinch amounted to 1,575,708 shares, leaving it with 10,184,292 shares, which is 6.46% of the total share capital [1][3]. - Chairman and General Manager Zhong Weifeng planned to reduce his holdings by up to 302,158 shares, which is 0.19% of the total share capital, and he successfully reduced 294,936 shares, retaining 913,698 shares, or 0.58% of the total [1][3]. Group 2: Reduction Plan Implementation - The reduction period for Zhong Weifeng was from March 13, 2025, to May 30, 2025, with a total reduction amounting to 8,526,906.60 yuan at a price range of 28.08 to 30.98 yuan per share [2][3]. - Taizhou Jinch's reduction period was from March 11, 2025, to May 30, 2025, with a total reduction amounting to 43,171,696.32 yuan at a price range of 23.64 to 30.53 yuan per share [2][3]. - Both shareholders decided to terminate the reduction plan early, having met their planned reduction amounts [3].